All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-22014121

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	22014121	A1762T	BCP		Carcinoma, Hepatocellular	G S C L	View
2	22014121	G1764A	BCP		Carcinoma, Hepatocellular	G S C L	View
3	22014121	A1032C	P	P	Carcinoma, Hepatocellular	G S C L	View
4	22014121	A1053G	P	P	Carcinoma, Hepatocellular	G S C L	View
5	22014121	A1126C	P	P	Carcinoma, Hepatocellular	G S C L	View
6	22014121	A1633G	X	X	Carcinoma, Hepatocellular	G S C L	View
7	22014121	A2574G	P	P	Carcinoma, Hepatocellular	G S C L	View
8	22014121	A2696G	P	P	Carcinoma, Hepatocellular	G S C L	View
9	22014121	A306G	P;S	P;S	Carcinoma, Hepatocellular	G S C L	View
10	22014121	A456G	P;S	P;S	Carcinoma, Hepatocellular	G S C L	View
11	22014121	C1485T	P;X	P;X	Carcinoma, Hepatocellular	G S C L	View
12	22014121	C2444A	P;C	P;C	Carcinoma, Hepatocellular	G S C L	View
13	22014121	C2586A	P	P	Carcinoma, Hepatocellular	G S C L	View
14	22014121	C2919T	P;X	P;X	Carcinoma, Hepatocellular	G S C L	View
15	22014121	C3026T	P;X	P;X	Carcinoma, Hepatocellular	G S C L	View
16	22014121	C928T	P	P	Carcinoma, Hepatocellular	G S C L	View
17	22014121	C955T	P	P	Carcinoma, Hepatocellular	G S C L	View
18	22014121	G1356A	P	P	Carcinoma, Hepatocellular	G S C L	View
19	22014121	G1499A	P;X	P;X	Carcinoma, Hepatocellular	G S C L	View
20	22014121	G1511A	P;X	P;X	Carcinoma, Hepatocellular	G S C L	View
21	22014121	G162A	P;S	P;S	Carcinoma, Hepatocellular	G S C L	View
22	22014121	G1727A	X	X	Carcinoma, Hepatocellular	G S C L	View
23	22014121	G2080A	C	C	Carcinoma, Hepatocellular	G S C L	View
24	22014121	G2783A	P	P	Carcinoma, Hepatocellular	G S C L	View
25	22014121	T1134C	P	P	Carcinoma, Hepatocellular	G S C L	View
26	22014121	T1323C	P	P	Carcinoma, Hepatocellular	G S C L	View
27	22014121	T3098C	P;X	P;X	Carcinoma, Hepatocellular	G S C L	View
28	22014121	C1653T	Core Promoter		Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S C L	View
29	22014121	G1613A	Core Promoter		Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.